The ideal imaging method in inflammatory bowel disease would reliably detect inflammation, identify the correct intestinal location, and assess the severity of the disease. The aim of this study was to compare scintigraphic methods of quantifying overall disease activity using both indium- (Gut 1995; 37: 679-683) 
HMPAO labelled leucocyte scans. The four day faecal excretion of "'In was measured after "'1In scintigraphy in 24 patients known to have inflammatory bowel disease. The same patients also underwent 99mTc HMPAO scanning. The scans were performed 10 days or less apart with no changes in treatment between scans. Bowel activity on the 99mTc HMPAO scans was assessed using a computer based method (scan score) and a visual grading method in a further 54 99mTc HMPAO The patients had a mean age of 43 years (range 17-68) and were equally distributed between male and female. The diagnosis, based on previous investigations, was Crohn's disease in 22 of the cases and ulcerative colitis in the remaining two. Six patients with Crohn's disease had undergone previous resective surgery, all surgery having been performed more than six months before the imaging. The disease duration, from diagnosis to scanning, ranged from three months to 22 years, mean eight years. The site of disease had not been fully determined by prior large and small bowel radiology in five patients, but was known to be limited to the colon in five, small bowel in eight, and present in both small and large bowel in six.
An additional 54 99mTc HMPAO scans, performed in the course of clinical assessment of disease activity, on 33 patients with Crohn's disease were analysed to compare the reproducibility of visual and computer assisted grading.
This study had the approval of the ethics committee of the former United Sheffield Hospitals and the Administration of Radioactive Substances Advisory Committee (ARSAC). The initial scan was clinically indicated to assess disease activity. Patients gave informed consent for the second (paired) scan. All scans were performed between February 1990 and January 1992. 1 1"Indium leucocyte labelling, imaging, andfaecal collection Autologous leucocytes were separated and labelled with "'In tropolonate as previously described.12 In summary, 60 ml of blood were taken into 5.5 ml of acid citrate dextrose. Ten ml were centrifuged at 1500 g for 10 minutes to obtain cell free plasma. The erythrocytes were removed from the remaining blood by hydroxyethyl sedimentation at room temperature. The supernatant was then centrifuged to permit separation of the leucocytes from the platelets. After washing, the leucocytes were labelled in plasma with tropolone and "'In chloride (Amersham International). Any free "'In was removed by a final wash in plasma, before reinjection. An average of 15 MBq of "'In labelled cells was injected into each patient.
A dynamic study of the posterior lung fields was performed for 15 minutes after reinjection to exclude any cell injury during labelling.6
Abdominal scans were performed at three hours after reinjection using a large field of view gammacamera. Faecal "'In excretion was measured on a four day collection, which started immediately after the scan. All patients were given clear written and verbal instructions regarding the faecal collection. The importance of acquiring a complete four day collection was stressed. All faecal collections were done on an outpatient basis.
99mTechnetium HMPAO labelling and imaging
The technique of labelling granulocytes in mixed leucocyte suspension using 99mTc HMPAO has previously been described. 13 Briefly, 102 ml of venous blood were taken into 18 ml of acid citrate dextrose. Twenty ml were centrifuged to obtain cell free plasma. Leucocytes were separated as described above and were resuspended in cell free plasma. Four ml of 99mTc HMPAO, reconstituted according to the manufacturer's instructions, were added to the leucocyte suspension, mixed gently, and left for 10 minutes at room temperature. After this the labelled cells were washed once with plasma before being transferred to a heparinised plastic syringe for reinjection. An average of 200 MBq of 99mTc labelled cells was injected into each patient.
As with the "'In scintigraphy, a dynamic study of the posterior lung fields was carried out for the first 15 minutes after injecting the radiolabelled leucocytes. No patients showed prolonged lung retention of labelled cells.
Subsequently anterior and posterior abdominal scans were obtained at 40 minutes and 120 minutes using a large field of view gammacamera (IGE 400T or Siemens ZLC 750 Digitrac), fitted with a low energy, high resolution collimator and interfaced to a microcomputer (Research Machines Nimbus PC20).
Quantitative assessment of leucocyte scans
Visual assessment -the 99mTc HMPAO scans acquired at 120 minutes were coded and scored blindly and independently by three physicians. A scoring system similar to that used by other investigators8 14 was used. The colon was divided into four regions (rectosigmoid, descending, transverse, and ascending) with a fifth region representing the small intestine. The imagine intensity in each region was compared with the distribution of isotope in the bone marrow (score 1), liver (score 2), and spleen (score 3). A score of 4 was assigned if the bowel intensity was greater than in the spleen. The addition of the scores for the five regions produced a visual grading score for the whole scan, with a potential range 0-20.
Computer generated scan score -using the image obtained at 120 minutes after reinjection of 99mTc a computer generated scan score was calculated. The method has been described previously.'0 In outline, the patient image is scaled in size to that of a standard image, which consists of spleen, liver, and bone marrow activity without localised bowel uptake. The standard or 'background' image is then scaled in amplitude and digitally subtracted by computer from the patient's image, leaving only the bowel related uptake. The scan score, which is a dimensionless quantity, is then calculated from the counts in a 20% contour based on the maximum intensity in the abnormal gut. This value is corrected for image acquisition time and injected dose by normalisation to the bone marrow uptake of the scaled standard image.
Determination of percentage faecal excretionthe indium activity excreted in the faeces was determined by counting each of the daily collections in a large volume sample gammacounter, equipped with a rotating table. The activity from all collections was summed and expressed as a percentage of the injected dose.
As the percentage of labelling of granulocytes in the mixed cell suspension in each patient was not known, it was necessary to assume that this was constant across all subjects.
Results

Twenty four patients underwent paired 99mTc
HMPAO and "1'In labelled scans. Three patients failed to complete their faecal collection despite verbal and written instructions of the procedure. A further patient became constipated during her four day collection after taking analgesia for a migraine attack. In this case the "'1In leucocyte scan performed at two hours was at variance with the low faecal excretion. After the problem of her constipation became apparent this result was excluded from the analysis.
One patient had uptake on her 99mTc HMPAO scan that did not conform to bowel outline. This remains an unexplained artefact.
She had a low faecal 1"'In excretion (2.8% of injected dose) and a repeat 99mTc HMPAO scan a few weeks later gave a correspondingly low scan score without repeat of the artefactual uptake. This is the only such artefact we have seen in over 200 99mTc HMPAO bowel scans.
The remaining 19 paired 99mTc HMPAO scan scores and percentage faecal "'1In excretion results showed a positive correlation (Fig  1) . The Spearman rank correlation coefficient (rs) was 0.78 (p<0001). The summated visual grading assessment in this study showed an unacceptable interobserver variation with 31% of scans having significant disagreement between three observers. This level of variation would preclude its use for assessment of overall inflammation in therapeutic trials as well as reducing its value in routine clinical practice. The computerised scan score showed better reproducibility and therefore seems to overcome this problem. The subtle nature of the changes in activity in response to treatment has been shown by the use of faecal "'lIn excretion for this purpose, the percentage "'lIn excretion fell from the increased values in active disease but did not revert to the range for normal controls or fully inactive disease.'4 15 Both the "'In and 99mTc HMPAO techniques used mixed leucocytes rather than pure granulocytes. In the case of the "'In label pure granulocytes and mixed leucocytes have been compared previously.6 Pure granulocyte preparations seemed to produce scans with clearer images and may deliver a lower radiation dose to lymphocytes. Active and inactive Crohn's disease could be distinguished using either pure granulocytes or mixed leucocytes.6 Using mixed cells for "'In scanning necessitates an assumption of constant labelling efficiency for granulocytes. The percentage "'IIn labelling of pure granulocytes in a mixed cell preparation has previously been found to be 31% (SD 60/o).6 Ideally this percentage needs to be known for each patient, however, this requires a density gradient separation of granulocytes from an aliquot of mixed cells, a technique that requires additional expertise and facilities, which may not always be available. As 99mTc HMPAO effectively labels granulocytes in a mixed cell preparation, further cell isolation procedures are unnecessary for this label. '3 In this study the injected activities were on average "'In 15 MBq and 99mTc HMPAO 200 MBq. The corresponding radiation doses have been calculated to be 6&75 cGy and 4-0 cGy to the spleen, 0 9 cGy and 0-2 cGy to the liver, and 1-65 cGy and 025 cGy to the bone marrow for "'In and 99mTc HMPAO respectively.'6 The radiation dosage is substantially lower with the 99mTc HMPAO scanning technique, however, using 99mTc HMPAO the image quality is superior to the "'IIn scans.
In conclusion, these results show that the 99mTc HMPAO scan score has value in quantification of overall disease activity. This is similar to the percentage faecal "'In excretion with which it correlates closely. 99mTc HMPAO scans avoid faecal collection, produce superior images, and expose the patient to less radiation than "'In scintigraphy. 99mTc HMPAO scans may therefore be the preferred method. 
